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Background: Glycine is a classical neurotransmitter that has role in both inhibitory and 30 
excitatory synapses. To understand whether glycinergic inputs are involved in the regulation of 31 
the hypophysiotropic thyrotropin-releasing hormone (TRH) neurons, the central controllers of 32 
the hypothalamic-pituitary-thyroid (HPT) axis, the glycinergic innervation of the TRH neurons 33 
was studied in the hypothalamic paraventricular nucleus (PVN). 34 
Methods: Double-labeling immunocytochemistry and patch clamp electrophysiology was used 35 
to determine the role of the glycinergic neurons in the regulation of TRH neurons in the PVN. 36 
Anterograde- and retrograde tracing methods were used to determine the sources of the 37 
glycinergic input of TRH neurons. 38 
Results:  Glycine transporter 2 (GLYT2), a marker of glycinergic neurons, containing axons 39 
was found to establish symmetric type of synapses on TRH neurons in the PVN. Furthermore, 40 
glycine receptor-immunoreactivity was observed in these TRH neurons. The raphe magnus 41 
(RMg) and the ventrolateral periaqueductal gray (VLPAG) were found to be the exclusive 42 
sources of the glycinergic innervation of the TRH neurons within the PVN. 43 
Patch-clamp electrophysiology using sections of TRH-IRES-tdTomato mice showed that 44 
glycine hyperpolarized the TRH neurons and completely blocked the firing of these neurons. 45 
Glycine also markedly hyperpolarized the TRH neurons in the presence of tetrodotoxin 46 
demonstrating the direct effect of glycine. In more than 60% of the TRH neurons, spontaneous 47 
inhibitory postsynaptic currents (sIPSC) were observed, even after the pharmacological 48 
inhibition of glutamatergic and GABAergic neuronal transmission. The glycine antagonist, 49 
strychnine, almost completely abolished these sIPSCs, demonstrating the inhibitory nature of 50 
the glycinergic input of TRH neurons.  51 
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Conclusions: These data demonstrate that TRH neurons in the PVN receive glycinergic inputs 52 
from the RMg and the VLPAG. The symmetric type of synaptic connection and the results of 53 
the electrophysiological experiments demonstrate the inhibitory nature of these inputs.  54 




Glycine is a classical neurotransmitter that has an important role in both inhibitory and 57 
excitatory synapses (1). Glycinergic neurons are primarily located in the brainstem and spinal 58 
cord (2), however, glycinergic axons are also observed in the hypothalamus (3). Two glycine-59 
transporter subtypes (GlyT) were identified in the central nervous system: glycine transporter-60 
1 (GlyT1), mainly located in glial cells and nerve terminals of excitatory neurons, and glycine 61 
transporter-2 (GlyT2), present exclusively in glycinergic neurons (4, 5).  62 
Glycine is released from inhibitory, presynaptic terminals and binds to strychnine-sensitive 63 
glycine receptors that are located in the postsynaptic membrane of target cells (1). Activation 64 
of glycine receptors leads to influx of chloride ions into the cytoplasm and thereby, inhibits the 65 
postsynaptic neuron (6). In addition, glycine is also important for excitatory glutamatergic 66 
neurotransmission because it serves as an essential co-agonist of glutamate at NMDA receptors 67 
(7). 68 
The hypothalamic paraventricular nucleus (PVN), where hypophysiotropic thyrotropin-69 
releasing hormone- (TRH)-synthesizing neurons, the main central regulators of the 70 
hypothalamic-pituitary-thyroid (HPT) axis reside(8), is densely innervated by glycinergic 71 
axons (3). Within the PVN, glycine has been shown to elicit large, inward currents (9). 72 
Furthermore, evoked glycinergic currents can be observed in parvocellular PVN neurons in the 73 
presence of the blockers of glutamate and GABA receptors (9), suggesting that ascending 74 
glycinergic pathways regulate parvocellular neurons in the PVN.  75 
Based on these data, we hypothesized that glycinergic brainstem neurons are involved in the 76 
regulation of the TRH neurons in the PVN including the hypophysiotropic TRH neurons. To 77 
test this hypothesis, we performed neuroanatomical and electrophysiological experiments. 78 
Since TRH neurons are dispersed in the PVN, identification of these cells was difficult in 79 
electrophysiological studies. In addition, in morphological studies, the cell bodies of TRH 80 
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neurons could only be identified after inhibition of axonal transport by colchicine treatment. 81 
Therefore, to facilitate both the electrophysiological and morphological studies, we generated 82 
a TRH-IRES-tdTomato knock in mouse line in which the TRH neurons can be easily identified 83 
based on the presence of the red fluorescent protein in their perikarya.  84 
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Materials and methods 85 
Animals 86 
The experiments were carried out in adult, male, CD1 mice (N=8), GlyT2::GFP mice (N=9) 87 
(3), TRH-IRES-tdTomato mice (N=30), double transgenic mice heterozygous for TRH-IRES-88 
tdTomato and GlyT2::Cre (10) (TRH-IRES-tdTomato//GlyT2::Cre; N=10), and, weighing 30–89 
40 g, housed under standard environmental conditions (light between 06:00 and 18:00 h, 90 
temperature 22±1oC, rat chow and water ad libitum). The in vitro patch clamp 91 
electrophysiology studies were performed on mice between P40 and P60 days of age. All 92 
experimental protocols were reviewed and approved by the Animal Welfare Committee at the 93 
Institute of Experimental Medicine of the Hungarian Academy of Sciences. 94 
 95 
Generation of the TRH-IRES-tdTomato mouse line 96 
An IRES tdTomato cassette was inserted into the mouse TRH locus using CRISPR/Cas9 (11) 97 
on FVB.129P2-Pde6b+ Tyrc-ch/AntJ (FVB/Ant) background. The 1473 bp long 5’ and the 98 
1375bp long 3’ TRH  arms were obtained by PCR on FVB/Ant gDNA (5’ TRH arm sense 99 
oligonucleotide: ccgctcgagCACCTTGGCACCCTGATACCAGGAA; antisense: 100 
tccccgcggTTACTCCTCC AGAGGTTCCCTGA; 3’ TRH arm sense: 101 
ataagaatgcggccgctGGTTAGAGTCAGGCTTT AGGTCTA; antisense: ctagctagc 102 
CTGGCATGGTGACTCATCTATAACAT). The 5’ arm was cloned between XhoI and SacII 103 
followed by IRES of the pPRIG vector (12) between SacII and EcoRI and the tdTomato coding 104 
region between EcoRI and NotI sites. The 3’ arm was placed between NotI and NheI. The 105 
construct was assembled in a D10 vector and confirmed by sequencing.  106 
Pronuclear microinjection was carried out on fertilized eggs of FVB/Ant mice, using of a single 107 
guide RNA with the target sequence of GGAGTAAGGTTAGAGTC and Cas9 mRNA 108 
(Trilink).  109 
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Founders were identified with qPCR for tdTomato (tdTomF GCTCCAAGGCGTACGTGAA, 110 
tdTomR GGAAGGACAGCTTCTTGTAATCG, tdTom_probe 6-FAM-111 
CACCCCGCCGACAT-MGBNFQ) followed by checking the insertion sites with outer and 112 
inner PCR oligos (CTTCCATGAGAGGAGTATTTATCA, 113 
CATGGACGAGCTGTACAAGTA, GGCCGCTATGACTTTAGCTTC, 114 
CTTACACCCACTGCCTTTGAC and GTAGTCAGGCACGTCGTATGG). A founder with a 115 
single copy of the targeting cassette was selected for breeding.  116 
Heterozygote F1 animals were crossbred with littermate animals of identical genotype. Mice 117 
were bred and maintained as homozygous colonies.  118 
 119 
Characterization of the TRH-IRES-tdTomato mice 120 
All solutions were made with MilliQ water treated with diethylpyrocarbonate (DEPC, 0.2µl/ml) 121 
overnight and then autoclaved. TRH-IRES-tdTOMATO mice (N=6) were deeply anesthetized 122 
with ketamine/xylazine (ketamine 50 mg/kg, xylazine 10 mg/kg body weight, ip) and the 123 
animals perfused transcardially with 10 ml 0.01 M PBS, pH 7.4, followed by 50 ml of 4% PFA 124 
in 0.1 M PB, pH 7.4. The brains were quickly removed, postfixed by immersion in the same 125 
fixative for 2 hours at RT, cryoprotected in 20% sucrose in PBS at 4°C overnight and then 126 
frozen using powdered dry ice. Serial 20-μm-thick coronal sections through the whole brain 127 
were cut on a cryostat (Leica Microsystems, Wetzlar, Germany), collected in freezing solution 128 
and stored at −20°C until used.  129 
The digoxigenin-labeled antisense mouse pro-TRH cRNA probe was synthesized using a 741‐130 
base (corresponding to the 106–846 nucleotides of the mouse TRH mRNA; BC053493) cDNA 131 
template (13) as described earlier (14). The hybridization was performed in 200 μl 132 
polypropylene tubes in a hybridization buffer (50% formamide, 2× SSC, 10% dextran sulfate, 133 
0.5% SDS, 250 μg/ml denatured salmon sperm DNA) containing the digoxigenin-labeled probe 134 
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(1:100 dilution) for 16 hr at 56°C. The sections were washed in 1× SSC for 15 min and then 135 
treated with RNase (25 μg/ml) for 1 hr at 37°C. After additional washes in 0.1× SSC (four times 136 
for 15 min each) at 65°C, sections were washed in PBS, treated with the mixture of 0.5% Triton 137 
X-100 and 0.5% H2O2 for 15 min, and then with 2% BSA in PBS for 20 min to reduce the 138 
nonspecific antibody binding. The sections were incubated with a mixture of sheep anti-139 
digoxigenin-peroxidase Fab fragments (1:100; Boehringer Mannheim) and rabbit anti-RFP 140 
serum (Rockland Immunochemicals Inc., Limerick, PA, USA, Indianapolis, IN, USA) diluted 141 
at 1:3000 in 1% BSA in PBS for 2 d at 4°C. The sections were rinsed in PBS and then the in 142 
situ hybridization signal was amplified using the TSA amplification kit according to the 143 
manufacturer’s instructions. After further washes, the sections were incubated in a mixture of 144 
Fluorescein DTAF-conjugated Streptavidin (1:300, Jackson Immunoresearch Labs, West 145 
Grove, PA, USA) and Alexa 555-conjugated donkey anti-rabbit IgG (1:500, Jackson 146 
Immunoresearch Labs, West Grove, PA) for 2 hours and mounted glass slides. Slides were air 147 
dried and coverslipped with Vectashield mounting medium (Vector Laboratories Inc, 148 
Burlingame, CA, USA). Images were taken with a Zeiss LSM 780 laser scanning confocal 149 
microscope.  150 
 151 
Generation of a sheep antibody against tdTomato 152 
The tdTomato coding region was inserted into a pET26b (+) vector (Merck, Darmstadt, 153 
Germany) by adding a C-terminal His-tag. Recombinant expression of His-tagged tdTomato 154 
was performed in Rosetta 2(DE3) E. Coli strain (Merck, Darmstadt, Germany). Induction was 155 
performed at 18 °C with 0.5 mM IPTG and the recombinant protein was expressed overnight. 156 
The cells were harvested by centrifugation at 4000xg for 30 min at 4 °C and the pellet was 157 
stored at -20 °C then resuspended in 20 ml lysis buffer (50 mM Tris base, 0.2 M NaCl, 5 % 158 
glycerin, 1 mM DTT, 1 mM TCEP, 1 mM PMSF supplemented with Roche Complete, Mini, 159 
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EDTA-free Protease Inhibitor Cocktail, pH 7.5) followed by lysis with 500 µg/ml lysozyme at 160 
4 °C for 4 h and further incubation with 5 mM MgCl2 and 1 mg/ml DNase. The His-tagged 161 
tdTomato was purified on 3 ml Ni-NTA column (ThermoFisher, Waltham, MA, USA) 162 
equilibrated with column buffer (20 mM Tris base, 200 mM NaCl, pH 7.5). After washing the 163 
column with 75 mM imidazole containing column buffer pure tdTomato fraction was eluted 164 
with 500 mM imidazole column buffer at pH 7.5. The eluted fraction was analyzed by SDS-165 
PAGE and dialyzed against 0.1M PBS. 166 
760 μg tdTomato in 1 ml PBS was emulsified with an equal volume of Freund’s complete 167 
adjuvant (Sigma-Aldrich, St. Louis, MO, USA) and injected subcutaneously into sheep. 168 
Subsequent boosts with Freund’s incomplete adjuvant were administered at 28-day intervals. 169 
Eight days after the fourth immunization, blood was collected and the serum was separated by 170 
centrifugation. 171 
 172 
Animal preparation for examination of the glycinergic input to TRH neurons in the PVN 173 
CD1 mice (N=8) were deeply anesthetized with ketamine/xylazine (ketamine 50 mg/kg, 174 
xylazine 10 mg/kg body weight, intraperitoneal (ip)) and the animals perfused transcardially 175 
with 10 ml 0.01 M phosphate-buffered saline (PBS), pH 7.4, followed sequentially by 50 ml of 176 
2% paraformaldehyde (PFA) / 4% acrolein in 0.1 M phosphate buffer (PB), pH 7.4, and then 177 
by 20 ml of 2% PFA in the same buffer. The brains were rapidly removed and stored in 4% 178 
PFA for 2 h for light microscopy (N=4) at room temperature (RT), or 24 h for electron 179 
microscopy (N=4) at 4oC. 180 
 181 
Sectioning and section pretreatment for light microscopic studies 182 
The brains were cryoprotected in 30% sucrose in PBS at 4oC overnight, then frozen using 183 
powdered dry ice. Serial, 25 µm thick coronal sections through the PVN were cut on a freezing 184 
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microtome (Leica Microsystems, Wetzlar, Germany), collected in cryoprotectant solution (30% 185 
ethylene glycol; 25% glycerol; 0.05 M PB) and stored at -20oC until used. Series of sections 186 
from each brain were treated with 1% sodium borohydride (Sigma-Aldrich, St. Louis, MO, 187 
USA) in distilled water (DW) for 30 min and with a mixture of 0.5% Triton X-100 and 0.5% 188 
H2O2 in PBS for 15 min. To reduce nonspecific antibody binding, the sections were treated with 189 
2% normal horse serum (NHS) in PBS for 20 min. 190 
 191 
Double-labeling immunofluorescence for examination of the glycinergic input of TRH neurons 192 
in the PVN 193 
Pretreated sections of CD1 mice were incubated in a mixture of rabbit anti-GlyT2 IgG (15, 16) 194 
and sheep anti-TRH IgG (1:4000) (17) in PBS containing 2% NHS and 0.2% sodium-azide 195 
(antiserum diluent) for 2 days at 4oC. After rinses in PBS, the sections were incubated in a 196 
mixture of Alexa 555-conjugated donkey anti-rabbit IgG (1:500, Jackson Immunoresearch Labs, 197 
West Grove, PA, USA) and Alexa 488-conjugated donkey anti-sheep IgG (1:500, Jackson 198 
Immunoresearch Labs, West Grove, PA, USA) in antiserum diluent. After rinses in PBS, the 199 
sections were mounted onto glass slides, and coverslipped with Vectashield mounting medium 200 
(Vector Laboratories Inc, Burlingame, CA, USA). 201 
 202 
Double labeling immuno- electron microscopy for examination of the glycinergic input of TRH 203 
neurons in the PVN 204 
Serial, 25µm thick coronal sections were cut on a Leica VT 1000S vibratome (Leica 205 
Microsystems, Wetzlar, Germany) through the rostro-caudal extent of the PVN and collected 206 
in PBS. The sections were treated with 1% sodium borohydride (Sigma-Aldrich, St. Louis, MO, 207 
USA) in 0.1 M PB for 30 min, followed by 0.5% H2O2 in PBS for 15 min. The sections were 208 
cryoprotected in 15% sucrose in PBS for 15 min at RT and in 30% sucrose in PBS overnight at 209 
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4oC and then, quickly frozen over liquid nitrogen and thawed at RT. This freezing-thawing 210 
cycle was repeated 3 times to improve antibody penetration. To reduce the nonspecific antibody 211 
binding, the sections were treated with 2% NHS in PBS for 20 min. Sections were placed into 212 
a mixture of rabbit anti-GlyT2 IgG (1µg/ml) and sheep anti-TRH IgG (1:1000) for 4 days at 213 
4oC. After rinsing in PBS and in a mixture of 0.1% cold water fish gelatin (Aurion, Wageningen, 214 
Netherlands) and 1% BSA (Sigma-Aldrich, St. Louis, MO, USA) in PBS, the sections were 215 
incubated in a cocktail of donkey anti-sheep IgG-conjugated with 0.8 nm colloidal gold (1:100, 216 
Electron Microscopy Sciences, Fort Washington, PA, USA) and biotinylated donkey anti-rabbit 217 
IgG (1:500, Jackson Immunoresearch Labs, West Grove, PA, USA) in the same cold water fish 218 
gelatin- and BSA-containing solution for 20 h at 4oC. After washing in PBS, the sections were 219 
fixed in 1.25% glutaraldehyde (Electron Microscopy Sciences, Fort Washington, PA, USA) in 220 
0.1M PB for 10 min. The gold particles were silver intensified with the Aurion R-Gent SE-LM 221 
Kit (Aurion, Wageningen, Netherlands) (18). After rinsing in 0.2M sodium citrate, pH 7.5, the 222 
sections were immersed in ABC Elite Complex (1:1000, Vector Laboratories Inc, Burlingame, 223 
CA, USA) diluted in 0.05M TRIS buffer for 1 hour at RT. The GlyT2 immunoreactivity was 224 
detected with NiDAB developer (0.025% DAB/0.0036% H2O2 in 0.05 M Tris buffer, pH 7.6). 225 
The sections were osmicated, and then treated with 2% uranyl acetate in 70% ethanol for 30 226 
min. Following dehydration in an ascending series of ethanol and acetonitrile, the sections were 227 
flat embedded in Durcupan ACM epoxy resin (Fluka, Sigma-Aldrich, St. Louis, MO, USA) on 228 
liquid release agent (Electron Microscopy Sciences, Fort Washington, PA, USA)-coated slides, 229 
and polymerized at 56 oC for 2 days. Ultrathin 50–60 nm sections were cut with Leica ultracut 230 
UCT ultramicrotome (Leica Microsystems, Wetzlar, Germany), collected onto Formvar-231 




Tissue preparation for the examination of the glycine receptor (GlyR) content of TRH neurons 234 
in the PVN 235 
TRH-IRES-tdTomato mice (N=5) were deeply anesthetized with ketamine/xylazine (ketamine 236 
50 mg/kg, xylazine 10 mg/kg body weight, ip) and perfused transcardially with 10 ml 0.01 M 237 
PBS, pH 7.4, followed by 50 ml of 4% PFA in 0.1 M PB, pH 7.4. The brains were rapidly 238 
removed, postfixed in 4% PFA for 2 hours at RT and cryoprotected in 30% sucrose in 0.01 M 239 
PBS overnight at room temperature. The brains were then frozen with powdered dry ice and 240 
stored at -20oC until use.  241 
Serial, 25 µm thick coronal sections through the PVN were cut on a freezing microtome, 242 
collected in cryoprotectant solution and stored at -20oC until use. 243 
Series of sections from each brain were subjected to pepsin pretreatment to facilitate antigen 244 
exposure (16).  The sections were incubated in 1 mg/ml pepsin (Dako Agilent, Santa Clara, CA, 245 
USA) for 7 min at 37 °C. After washing in PBS, the sections were treated with 0.5% Triton X-246 
100/0.5% H2O2 in PBS for 15 min, immersed in 2% NHS in PBS for 20 min and then incubated 247 
in a mixture of guinea pig-GlyRa IgG (15) (16) and rabbit-RFP antiserum (1:3000, Rockland 248 
Immunochemicals Inc., Limerick, PA, USA) in antiserum diluent for 2 days at 4oC. After rinses 249 
in PBS, the sections were incubated in biotinylated donkey anti-guinea pig IgG (1:500, Jackson 250 
Immunoresearch Labs, West Grove, PA, USA) for two hours and in ABC Elite Complex 251 
(1:1000, Vector Laboratories Inc, Burlingame, CA, USA) in 0.05M TRIS buffer for an hour. 252 
The immunoreaction was amplified with biotinylated tyramide using the TSA amplification kit 253 
(Perkin Elmer Life and Analytical Sciences, Waltham, MA, USA). After further washes, the 254 
sections were incubated in a mixture of the Fluorescein DTAF-conjugated Streptavidin (1:300, 255 
Jackson Immunoresearch Labs, West Grove, PA, USA) and Alexa 555-conjucated donkey anti-256 
rabbit IgG (1:500, Jackson Immunoresearch Labs, West Grove, PA, USA), mounted onto glass 257 
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slides and coverslipped with Vectashield mounting medium (Vector Laboratories Inc, 258 
Burlingame, CA, USA). 259 
 260 
Retrograde tract-tracing and tissue preparation for the identification of the sources of the 261 
glycinergic innervation of the PVN  262 
The retrograde tracer, cholera toxin β subunit (CTB; List Biological Labs, Campbell, CA, 263 
USA), was injected by iontophoresis into the PVN of GlyT2/GFP mice (N=9). The animals 264 
were anesthetized ip with ketamine-xylazine (ketamine: 50 mg/kg; xylazine: 10 mg/kg body 265 
weight) and their head positioned in a stereotaxic apparatus with the Bregma and Lambda in 266 
the horizontal plane. Through a burr hole in the skull, a glass micropipette (17.5-20 μm outer 267 
tip diameter) filled with 0.5% CTB in 0.01M PB at pH 8.0 was lowered into the brain at 268 
stereotaxic coordinates corresponding to the PVN (anterior–posterior, -0.9 mm from the 269 
Bregma; lateral, -0.15 mm; and dorsoventral, -4.8 mm from the surface of the skull), based on 270 
the atlas of Paxinos and Watson (19). CTB was deposited over 3 min of positive current (4 μA, 271 
pulsed on—off at 7s intervals) using a constant-current source (Stoelting, Wood Dale, IL, 272 
USA). The animals were anesthetized 7–10 days after tracer deposition and perfused with 10 273 
ml PBS, pH 7.4, followed by 50 ml of 4% paraformaldehyde in 0.1 M PB, pH 7.4. The brains 274 
were rapidly removed, postfixed in 4% PFA for 2 hours at RT, cryoprotected in 30% sucrose 275 
in PBS overnight at RT, then frozen using powdered dry ice and stored at -20oC until use. 276 
Twenty-five-μm-thick coronal sections were cut on a freezing microtome into one-in-four 277 
series of sections. 278 
 279 
Immunohistochemically identification of the CTB injection sites 280 
Series of sections was pre-treated as described above and then incubated in goat anti-CTB 281 
serum (1:10000, List Biological Labs, Campbell, CA, USA) for 2 days. Following washes in 282 
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PBS, the sections were immersed in biotinylated donkey anti-sheep IgG (1:500, Jackson 283 
Immunoresearch Labs, West Grove, PA, USA) for 2 h and in ABC (1:1000, ABC Elite, Vector 284 
Laboratories Inc, Burlingame, CA, USA) diluted in 0.05M Tris buffer for one hour. Following 285 
rinses in PBS, peroxidase activity was visualized with NiDAB developer. The sections were 286 
mounted on gelatin coated slides, air dried, counterstained with 1% cresyl-violet and 287 
coverslipped with DPX mounting medium (Sigma-Aldrich, St. Louis, MO, USA).  288 
 289 
Double-labeling immunofluorescence for the identification of the sources of the glycinergic 290 
input of the PVN  291 
One of the four series of sections was pre-treated as described above and incubated in a mixture 292 
of goat anti-CTB serum (1:5000, List Biological Labs, Campbell, CA, USA) and rabbit anti-293 
GFP serum (1:0,000, Life technologies) for 2 days at 4°C. Then, the sections were immersed in 294 
biotinylated donkey anti-sheep IgG (1:500, Jackson Immunoresearch Labs, West Grove, PA, 295 
USA) for 2 h, followed by ABC (1:1000, ABC Elite, Vector Laboratories Inc, Burlingame, CA, 296 
USA) for 2 hours. The immunoreaction product was amplified with TSA amplification kit for 297 
10 min. The signals were visualized by incubation in a mixture of Alexa 488-conjugated donkey 298 
anti-rabbit IgG (1:500, Jackson Immunoresearch Labs, West Grove, PA, USA) and Alexa 555-299 
conjugated Streptavidin (1:500, Jackson Immunoresearch Labs, West Grove, PA, USA) for two 300 
hours, mounted onto glass slides and coverslipped with Vectashield mounting medium (Vector 301 
Laboratories Inc, Burlingame, CA, USA). 302 
 303 
Virus injection and tissue preparation for the identification of the sources of the glycinergic 304 
innervation of the TRH neurons in the PVN 305 
As our retrograde tract-tracing experiment showed that the VLPAG and the RMg are the 306 
sources of the glycinergic input of the PVN, DIO-hChR2(H134R)-eYFP adeno-associated virus 307 
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(AAV) was injected to the VLPAG (N=5) or RMg (N=5) in TRH-IRES-tdTomato//GlyT2-Cre 308 
mice. The Cre expression in the GLYT2 cells allowed the glycinergic neuron specific 309 
expression of the hChR2(H134R)-eYFP fusion protein, while the tdTomato expression of TRH 310 
neurons facilitated the detection of TRH neurons. The surgeries were performed in a BSL-2 311 
AAV facility. The mice were anesthetized ip with ketamine-xylazine (ketamine: 50 mg/kg; 312 
xylazine: 10 mg/kg body weight) and their head positioned in a stereotaxic apparatus with the 313 
Bregma and Lambda in the horizontal plane. Through a burr hole in the skull, a glass pipette 314 
(25-μm tip) connected to a Nanoject II/Nanoliter 2000 microinjector (WPI Inc., Sarasota, FL, 315 
USA) was lowered into the brain at stereotaxic coordinates corresponding to the VLPAG 316 
(anteroposterior: -4.72 mm, mediolateral: -0.4 mm, dorsoventral: -2.75 mm), or RMg 317 
(anteroposterior: -5.34 mm, mediolateral: 0 mm, dorsoventral: -5.7mm) based on the atlas of 318 
Paxinos and Watson (19). 80 nl (RMg) and 150 nl (VLPAG) of virus-containing solution (4.5 319 
x1012 virus/ml, titer: 1x10^13 GC/ml) was injected unilaterally into the nuclei at a rate of 320 
5nl/sec. Five minutes after the injection, the pipette was slowly removed, the scalp sutured and 321 
the mice housed in BSL-2 quarantine for 2 weeks before experimentation. The animals were 322 
re-anaesthetized and perfused transcardially with 10 ml 0.01 M PBS, pH 7.4, followed by 50 323 
ml of 4% PFA in 0.1 M PB, pH 7.4. The brains were rapidly removed and postfixed in 4% PFA 324 
for 2 hour at RT. The brains were cryoprotected in 30% sucrose in 0.01 M PBS overnight at 325 
room temperature, frozen using powdered dry ice and stored at -20oC until use. Twenty-five-326 
μm-thick coronal sections were cut on a freezing microtome through the PVN and VLPAG or 327 




Localization of virus injection sites 330 
Series of sections containing the VLPAG or RMg were mounted onto glass slides and 331 
coverslipped with DAPI containing Vectashield mounting medium (Vector Laboratories Inc, 332 
Burlingame, CA, USA). The injection sites were detected based on the fluorescence of YFP. 333 
 334 
Tissue preparation for examination of the innervation of TRH neurons by glycinergic neurons 335 
of the VLPAG and RMg  336 
Sections of the PVN pre-treated as described above were incubated in a mixture of primary 337 
antisera: rabbit anti-GFP (1:10,000, ThermoFisher, Waltham, MA, USA) and sheep anti-338 
tdTomato (1:80,000, generated in our laboratory) for 48h. After washing in PBS, sections were 339 
incubated in the cocktail of Alexa 488-conjucated donkey anti-rabbit IgG (1:250, Invitrogen) 340 
and Alexa 555-conjugated donkey anti-sheep IgG (1:500, Invitrogen, Carlsbad, CA, USA) for 341 
2 h, mounted onto glass slides and coverslipped with Vectashield mounting medium.  342 
 343 
Image analyzes of light microscopic preparations 344 
Images of fluorescent preparations were taken using Zeiss LSM 780 confocal microscope 345 
(Zeiss Company, Jena, Germany) using line by line sequential scanning with laser excitation 346 
lines 490-553 nm for Alexa Fluor 488 and 566-697 nm for Alexa Fluor 555; 347 
beamsplitter/emission filters, MSB488/561 nm for Alexa Fluor 488 and Alexa Fluor 555. For 348 
20x and 63x oil lenses, pinhole sizes were set to obtain optical slices of 2 and 0.7 µm thickness, 349 
respectively, and the series of optical sections were recorded with 0.6 µm Z steps. 350 
Images were analyzed with Zen 2012 (Zeiss Company, Jena, Germany) and with Adobe 351 
Photoshop (Adobe System Inc., CA, USA). 352 
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Images of NiDAB stained preparations were captured with a Zeiss AxioImager M1 353 
microscope using AxioCam MRc 5 digital camera (Zeiss Company, Jena, Germany) and 354 
AxioVision 4.6 software (Zeiss Company, Jena, Germany). 355 
 356 
Specificity of the used antibodies 357 
The specificity of rabbit anti-GlyT2 IgG (16), sheep anti-TRH IgG (17), guinea pig-GlyRa 358 
IgG (16)  was previously described. The rabbit anti-RFP antibody (Rockland Immunochemicals, 359 
Limerick, PA, USA) and the rabbit anti-GFP serum (ThermoFisher, Waltham, MA, USA) did 360 
not generate any immunoreactivity on sections of wild type mice. The goat anti-CTB serum (List 361 
Biological Labs, Campbell, CA, USA) did not give any staining on sections of mice without 362 
tracer injection. The sheep antibody against tdTomato that was generated in our laboratory did 363 
not generate any staining on sections of wild type mice and the antibody did not crossreact with 364 
YFP. 365 
 366 
In vitro Patch-Clamp Electrophysiology 367 
Slice preparation for electrophysiological recordings  368 
   TRH-IRES-tdTomato mice (N=9) were deeply anaesthetized with isoflurane and decapitated. 369 
The brains were rapidly removed and immersed in ice-cold slicing solution (in mM: 87 NaCl, 370 
2.5 KCl, 0.5 CaCl2, 7 MgCl2, 25 NaHCO3, 25 D-glucose, 1.25 NaH2PO4, 75 sucrose) saturated 371 
with 95% O2/5% CO2. Coronal 250 µm slices were cut using a VT1200S vibratome (Leica 372 
Microsystems, Wetzlar, Germany), then the slices transferred into a holding chamber filled with 373 
artificial cerebrospinal fluid (aCSF; 36°C; in mM: 126 NaCl, 2.5 KCl, 26 NaHCO3, 2 CaCl2, 2 374 
MgCl2, 1.25 NaH2PO4, 10 glucose; pH 7.4; 280-300 mOsm/L). The slices were kept in holding 375 




Chemicals used for electrophysiology 378 
The chemicals for the intracellular and extracellular solutions, glycine and strychnine 379 
hemisulfate salt were purchased from Sigma-Aldrich (St. Louis, MO, USA). Tetrodotoxin 380 
(TTX), 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide 381 
(Gabazine), and 4-Hydroxyquinoline-2-carboxylic acid sodium salt (kynurenic acid sodium 382 
salt, KYNA) were purchased from the Tocris Bioscience (Bristol, UK).  383 
 384 
Data acquisition and analysis  385 
The slices were transferred to a submersion type recording chamber containing aCSF at 32-33 386 
°C and were perfused with aCSF at a rate of approximately 3 mL/min. TRH neurons were 387 
identified by the red fluorescence of the tdTomato under short epifluorescent illumination using 388 
an FN1 Microscope (Nikon, Tokio, Japan) equipped with 40x water-immersion objective with 389 
additional zoom (up to 2x) and Zyla CCD camera (ANDOR). Afterwards, the selected cell was 390 
studied under infrared differential interference contrast illumination. The patch pipettes (6-7 391 
MΩ) were pulled from borosilicate capillaries (OD=1.5 mm thin wall, Garner Co, Maharashtra, 392 
India.) with a P-1000 horizontal puller (Sutter Instrument Co., Novato, CA, USA). The 393 
intracellular pipette solution used for current-clamp (I=0) electrophysiological recordings 394 
contained (in mM) 110 K-gluconate, 4 NaCl, 20 HEPES, 0.1 EGTA, 10 phosphocreatine di(tris) 395 
salt, 2 ATP, 0.3 GTP (pH 7.25; 280-300 mOsm/L). For sIPSC recording, the intracellular 396 
solution had the following composition: (in mM) 130 CsCl, 8 NaCl, 0.1 CaCl2, 0.1 EGTA, 10 397 
HEPES, 4 Mg-ATP, 0.3 Na2-GTP, 5 Lidocaine N-ethyl bromide (pH 7.25; 280–300 mOsm/L). 398 
Recordings were performed with a Multiclamp 700B patch clamp amplifier, Digidata-1440A 399 
data acquisition system and pCLAMP 10.4 software (Molecular Devices). The headstage of the 400 
amplifier was fitted onto a Luigs&Neumann SM7 micromanipulator system. Whole-cell 401 
current-clamp recordings were filtered at 10 kHz using the built-in Bessel filter of the amplifier 402 
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and digitized at 10 kHz. Slow and fast capacitive components were automatically compensated 403 
for. The stability of the patch was checked by repetitively monitoring the access resistance 404 
during the experiment, and TRH neurons in which the series resistance changed >25% were 405 
excluded from the statistics. Liquid junction potential was 14.4 mV and not compensated.  406 
 407 
Whole-cell patch clamp recording 408 
After establishing a stable, whole-cell patch-clamp recording, a control period was recorded for 409 
2-3 min that was followed by a drug treatment phase for 3-4 min. First, the effect of glycine 410 
(0.5 mM) was measured on the firing frequency of TRH neurons in the presence or absence of 411 
the glycine receptor inhibitor, strychnine (125 μM), in current-clamp mode (IC). Then, the 412 
voltage-dependent sodium channel inhibitor, TTX (1.2 mM), was added to the aCSF to prevent 413 
the potential indirect effects of glycine treatment, and the effect of glycine was also examined 414 
in the presence or absence of strychnine. The washout of the drugs restored the spiking 415 
frequency or the membrane potential of TRH neurons in all cases. 416 
For glycinergic sIPSC recordings, cells were voltage clamped using a whole-cell clamp 417 
configuration at a holding potential of -63 mV, the average resting membrane potential of the 418 
TRH neurons. A control value was recorded for 2-3 min in the presence of Gabazine (3 μM) 419 
and KYNA (1 mM) to inhibit the effects of the GABAergic or glutamatergic inputs, followed 420 
by application of strychnine in the presence of Gabazine and KYNA for 3-4 min. 421 
 422 
Statistical analysis of the data of electrophysiological recordings 423 
Changes of spiking frequency, membrane potential and sIPSC recording were analyzed with 424 
Clampfit module of the pCLAMP 10.4 software (Molecular Devices, San José, CA, USA) and 425 
OriginPro 2015. Statistical analysis was performed using one-way analysis of variance 426 
(ANOVA) followed by the Bonferroni post hoc test to determine differences among treatment 427 
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groups in the current-clamp experiments, and the paired t-test was carried out in the voltage-428 
clamp experiment. The number of studied cells is described in the results of each experiment. 429 
All data are reported as mean ± standard error of mean (SEM). The p value <0.05 was 430 
considered significant in all cases.  431 
 432 




Colocalization of tdTomato-immunoreactivity and proTRH mRNA in the PVN of TRH-IRES-435 
tdTomato mice 436 
Drying results in fading of tdTomato’s fluorescence, therefore its detection was performed by 437 
immunofluorescence in TRH-IRES-tdTomato mice. The distribution of tdTomato 438 
immunofluorescence (Fig. 1A) was found to be identical with the known distribution of TRH 439 
in the hypothalamus. In situ hybridization combined with immunofluorescence demonstrated a 440 
complete overlap between tdTomato-immunofluorescence and the in situ hybridization signal 441 
detecting the proTRH mRNA in the PVN. This demonstrated the selectivity and specificity of 442 
tdTomato expression in the generated TRH-IRES-tdTomato mice (Fig. 1B, C).  443 
 444 
TRH neurons receive GLYT2-IR innervation in the PVN 445 
GlyT2-IR axons were observed in close proximity to TRH-IR neurons in all subdivisions of the 446 
PVN where TRH neurons are located. By double-labeling immunofluorescence, large GLYT2-447 
IR varicosities were observed on the surface of TRH-IR neurons (Fig 2). Quantification of the 448 
interaction of the two systems showed that GlyT2-IR axon varicosities established contacts with 449 
53±2% of TRH neurons. An average of 1.9±0.1 GlyT2-IR contacts were found on the surface 450 
of the innervated TRH neurons. At the ultrastructural level, synaptic associations were observed 451 
between NiDAB-labeled, GlyT2-IR varicosities and TRH neurons labeled with silver 452 
intensified colloidal gold particles (Fig. 3). Both axo-somatic and axo-dendritic synapses were 453 
found between the two systems. All of the observed synaptic associations were of the symmetric 454 




TRH neurons express glycine receptors in the PVN 457 
To understand whether glycine released from axon terminals can influence TRH neurons in the 458 
PVN, the glycine receptor content of TRH neurons was studied in TRH-IRES-tdTomato mice. 459 
Punctuate GLYR-immunoreactivity was observed in all TRH neurons in all subdivisions of the 460 
PVN (Fig. 4). 461 
 462 
The ventrolateral PAG and the raphe magnus are the sources of the glycinergic input of TRH 463 
neurons in the PVN 464 
As a first step, the retrograde tracer CTB was injected into the PVN of GlyT2::GFP mice to 465 
investigate the origins of the glycinergic input of the PVN. CTB injection sites localized well 466 
within the borders of the PVN (Fig. 5) were used for the colocalization of CTB-467 
immunoreactivity and GFP, the latter labeling glycinergic neurons. Double-labeled PVN 468 
projecting glycinergic neurons were observed in only two regions of the brainstem: in the RMg 469 
and VLPAG (Fig. 5).  470 
To determine whether the TRH neurons of the PVN receive glycinergic input from both of these 471 
brainstem nuclei, hChR2(H134R)-eYFP fusion protein was expressed specifically in the 472 
glycinergic neurons of the RMg or the VLPAG of TRH-IRES-tdTomato//GlyT2::Cre mice 473 
using AAV mediated gene transfer. The AAV injection site was centered within the RMg in 4 474 
mice and in the VLPAG in 6 mice (Fig 6A, J). Axons of glycinergic neurons of RMg origin 475 
innervated symmetrically both parts of the PVN. While these axons densely innervated all 476 
parvocellular subdivisions of the PVN (Fig. 6 B-D), the magnocellular division of the PVN 477 
received less dense innervation. Glycinergic axons of VLPAG origin innervated primarily the 478 
ipsilateral side of the PVN, but sparse glycinergic axons were also observed on the contralateral 479 
side. Higher magnification images (Fig. 6E-I, N-Q) demonstrated that glycinergic axons 480 
originating from both the RMg and VLPAG contacted TRH neurons in all parvocellular 481 
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subdivisions of the PVN, demonstrating that the glycinergic input of TRH neurons originate 482 
from both the RMg and the VLPAG. 483 
 484 
Glycine inhibits the firing of TRH neurons in the PVN 485 
To understand the role of glycine in the regulation of TRH neurons, the effects of this amino 486 
acid transmitter was studied on the membrane potential and firing of TRH neurons in the mid 487 
level of PVN of TRH-IRES-tdTomato mice, where the hypophysiotropic TRH neurons are 488 
enriched (13). Application of glycine markedly decreased the membrane potential (-14.23±2.55 489 
mV; n=6, P<0.001; Fig. 7) and completely blocked the firing (control: 3.15±0.52 Hz vs. glycine: 490 
0.08±0.08 Hz, n=6, P<0.001; Fig. 7) of TRH neurons. Co-application of strychnine completely 491 
prevented the glycine-induced changes of the membrane potential (0.16±1.65 mV, P=1 vs. 492 
control and P<0.001 vs. glycine, n=6; Fig. 7) and the firing rate (0.38±0.54 Hz, P=1 vs. control 493 
and P<0.001 vs. glycine, n=6; Fig. 7) of TRH neurons.  494 
To understand whether the inhibitory effect of glycine is exerted directly on the TRH neurons, 495 
the effect of glycine was also studied in the absence of neuronal inputs in TTX (1.2 mM) treated 496 
slides. Application of glycine caused an approximately 6 mV hyperpolarization of TRH neurons 497 
(control: -63.20±0.94 mV vs. Gly: -69.84±0.65 mV, n=5, P=0.0011; Fig. 7 D, E) even in the 498 
presence of TTX. Application of strychnine abolished this effect of glycine (-64.11±1.58 mV, 499 
n=5; Fig. 7 D, E). 500 
 501 
TRH neurons receive spontaneous inputs from glycinergic terminals 502 
To demonstrate the involvement of the glycinergic inputs in the regulation of TRH neurons of 503 
the PVN, the spontaneous glycinergic currents of these cells were studied in TRH-IRES-504 
tdTomato mice. Glycinergic sIPSCs were isolated by simultaneous inhibition of the 505 
glutamatergic and GABAergic inputs with a mixture of KYNA and Gabazine. Despite the 506 
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presence of these inhibitors, sIPSCs were observed in 62.5% of TRH neurons. The frequency 507 
of these sIPSCs was 0.824±0.19 Hz (Fig. 8). Strychnine markedly decreased the frequency of 508 
these sIPSCs (0.12±0.04 Hz, n=5, P=0.038; Fig. 8) suggesting that glycinergic synaptic inputs 509 
inhibit a population of TRH neurons. In 37.5% of the studied TRH neurons (n=3), the frequency 510 
of sIPSCs was only 0.080±0.014 Hz after inhibition of GABAergic and glutamatergic currents 511 
cells with vs. without glycinergic sIPSC: P=0.028). Strychnine had no effect on the sIPSC 512 





An important function of the HPT axis is to maintain stable thyroid hormone levels in the 516 
circulation under normal conditions and thus, to provide a continuous supply of thyroid 517 
hormones for tissues (8). This function is primarily controlled by the negative feedback effect 518 
of thyroid hormones on hypophysiotropic TRH neurons and pituitary thyrotrophs (8). Under 519 
certain conditions, such as fasting, infection or cold exposure, however, the activity of the HPT 520 
axis is altered by neuronal inputs or by the activity of tanycytes (8). Peptidergic inputs 521 
originating from the arcuate nucleus are known to mediate the effects of fasting and leptin 522 
treatment on the hypophysiotropic TRH neurons (8), while adrenergic innervation stimulates 523 
the hypophysiotropic TRH neurons during cold exposure (20). Our laboratories described that 524 
the TRH neurons of the PVN also receive inputs from neurons utilizing classical 525 
neurotransmitters such as GABA and glutamate (21, 22). Since glycinergic axons are also 526 
present in the PVN (3), we investigated whether TRH neurons are also controlled by glycine to 527 
regulate the thyroid axis. 528 
To facilitate these studies, we generated a novel knock in mouse model expressing tdTomato 529 
specifically in TRH-producing cells using the CRISPR/Cas9 technology. By combined 530 
immunocytochemistry and in situ hybridization, we showed that there is a complete overlap of 531 
tdTomato protein and the proTRH mRNA in the PVN of these mice, indicating that the TRH-532 
IRES-tdTomato mouse line allows specific identification of the TRH neurons. This new mouse 533 
line also enabled us to study the electrophysiology of TRH neurons and identify the TRH 534 
neurons in morphological studies without the use of colchicine, an axonal transport inhibitor. 535 
Our presented data demonstrate that glycinergic neurons innervate approximately half of the 536 
TRH neurons in the PVN, establishing symmetric type synapsis suggesting the inhibitory nature 537 
of these connections (23, 24). In addition, we show that the vast majority of TRH neurons 538 
express glycine receptors. In agreement with these morphological findings, exogenous glycine 539 
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inhibited all TRH neurons studied in the PVN. Namely, glycine treatment markedly 540 
hyperpolarized TRH neurons and almost completely abolished the firing of these cells.  541 
While approximately half of the TRH neurons received glycinergic innervation, almost all TRH 542 
neurons in the PVN contained glycine receptors and responded to glycine treatment. This 543 
discrepancy raised the question whether the sensitivity of the immunocytochemical method was 544 
insufficient to detect all of the glycinergic input to TRH neurons, or whether the glycine 545 
receptors of these neurons have other roles in addition to the detection of synaptically-released 546 
glycine. To address this question, we studied the glycinergic sIPSCs of TRH neurons.   547 
After inhibition of glutamatergic and GABAergic currents, sIPSCs were still observed in 548 
approximately 60% of TRH neurons in the PVN. Administration of strychnine almost 549 
completely blocked the sIPSCs, demonstrating that endogenous glycine released from neuronal 550 
terminals exerts an inhibitory effect on TRH neurons in the PVN. However, glycinergic sIPSCs 551 
were not observed in approximately 40% of TRH neurons in the PVN. These data indicate that 552 
extrasynaptic glycine receptors are also involved in the regulation of TRH neurons. 553 
In addition to glycine, taurine is also a known ligand of glycine receptors (25). In the supraoptic 554 
nucleus (SON), Deleuze et al (25) showed that the neurons express glycine receptors, but do 555 
not receive functional glycinergic synapses. Furthermore, they observed that the glycine 556 
receptor expressing cells are contacted by taurine containing astrocytes (22, 25). Based on these 557 
observations, they suggested that the ligand of glycine receptor in the SON is taurine, released 558 
from astrocytes (25). Thus, it seems feasible that TRH neurons in the PVN may also be 559 
regulated by both glycine, released from neuronal inputs, and by taurine, secreted by astrocytes 560 
and will require further investigation.   561 
Although, glycinergic neurons are present in most parts of the brainstem, the origin of the 562 
glycinergic input to TRH neurons in the PVN is restricted to two, brainstem nuclei, the VLPAG 563 
and RMg. The role of these nuclei in the regulation of the TRH neurons and the HPT axis is 564 
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currently unknown. Published data, however, indicate that some of the conditions known to 565 
inhibit the HPT axis, such as the administration of bacterial lipopolysaccharide (LPS), a model 566 
of infection or different stressors (8), induces neuronal activation in the VLPAG and RMg (10, 567 
25-30). Thus, further studies are needed to determine whether projections from glycinergic 568 
neurons in these two, brainstem regions to TRH neurons in the PVN have a role in the mediation 569 
of the stress and LPS-induced inhibition of the hypophysiotropic TRH neurons and the HPT 570 
axis.   571 
Glycinergic inputs of TRH neurons found not only in the mid level of the PVN, where the 572 
hypophysiotropic TRH neurons are concentrated (13), but also in other regions of the PVN, like 573 
in the anterior parvocellular subdivision, where the TRH neurons have no hypophysiotropic 574 
function (13). Therefore, our data indicate that glycine regulates both hypophysiotropic and 575 
non-hypophysiotropic populations of the TRH neurons in the PVN. Currently very little 576 
information is available about the function of non-hypophysiotropic TRH neurons of the PVN. 577 
The TRH neurons residing in the anterior parvocellular subdivision of the PVN were, however, 578 
shown to project to energy homeostasis-related areas, like the arcuate and ventromedial nuclei 579 
{Wittmann, 2009 #22}, thus it is feasible that the glycinergic neurons regulate the energy 580 
homeostasis via the non-hypophysiotropic TRH neurons. 581 
In summary, these data demonstrate that TRH neurons in the PVN receive a functional, 582 
glycinergic input from the VLPAG and the RMg that exert an inhibitory effect on the TRH 583 
neurons, indicating that the glycinergic system may have an important role in the central 584 
regulation of the HPT axis. However, as not all TRH neurons in the PVN are innervated by 585 
glycinergic inputs yet responsive to glycine in vitro, we hypothesize that glial release of glycine 586 
or taurine, or yet another glycine receptor agonist, may also influence TRH neurons via glial-587 
neuronal interactions. 588 
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Figure 1. Characterization of the TRH-IRES-tdTomato mice. Low magnification image (A) 692 
illustrates that the distribution of the tdTomato-immunoreactivity in the TRH-IRES-tsTomato 693 
mice is identical with the known distribution of TRH in the hypothalamus. Double-labeling 694 
combined in situ hybridization and immunofluorescence (B) demonstrate the complete overlap 695 
of tdTomato (red) and proTRH mRNA (silver grain) in the PVN. Higher magnification image 696 
(C) shows the colocalization of the two signals in the PVN. Scale bars on A and B = 100µm, 697 
on C = 50µm.  698 




Figure 2. Relationship of GLYT2-IR axons and TRH-IR neurons in the PVN of CD1 mice. 701 
GlyT2-IR (red) axons were observed in close proximity of the TRH-IR (green) neurons in all 702 
subdivisions of the PVN. A-C figures show the relationship of GLYT2-IR axons and TRH 703 
neurons in the anterior (A), mid (B) and posterior (C) levels of the PVN. Higher magnification 704 
images illustrate the GLYT2-IR boutons (arrowheads) on the surface of TRH neurons in the 705 
anterior (D), mid (E) and posterior (F) levels of the PVN. Scale bars= 20 µm, Scale bar on A 706 
corresponds to A-C, Scale bar on D corresponds to D-F. 707 




Figure 3. GLYT2-IR varicosities establish symmetric type synapses on TRH neurons in the 710 
PVN of CD1 mice. At the ultrastructural level, synaptic associations were observed between 711 
NiDAB labeled GlyT2-IR varicosities and TRH neurons labeled with silver intensified colloidal 712 
gold particles. Both axo-somatic (A, and in higher magnification on B), and axo-dendritic 713 
synapses (C) were found between the two systems. These synaptic associations were of 714 




Figure 4. Presence of glycine receptor-immunoreactivity in the TRH neurons in the PVN of 717 
TRH-IRES-tdTomato mice. Punctuate glycine receptor-immunoreactivity (green) is present in 718 
all TRH neurons (red) studied. Scale bar = 5µm 719 
 720 
Figure 5. Origin of the glycinergic input of the PVN of GLYT2::GFP mice. (A) illustrates a 721 
representative CTB injection site. The CTB immunoreactivity was visualized using NiDAB 722 
chromogen. Nissl staining was used to facilitate the identification of the borders of the PVN. 723 
Immunofluorescent preparations demonstrate the presence of the PVN projecting (red, CTB-724 
immunoreactive) glycinergic neurons (green, GLYT2-GFP) in the RMg (B) and VLPAG (C). 725 




Figure 6. Involvement of the glycinergic neurons of the RMg and VLPAG in the innervation 728 
of the TRH neurons in the PVN of TRH-IRES-tdTomato//GlyT2::Cre mice. A representative 729 
image (A) illustrates the AAV mediated expression of hChR2(H134R)-eYFP fusion protein 730 
(green) in RMg gylcinergic neurons of TRH-IRES-tdTOMATO//GlyT2-Cre mice. Low 731 
magnification images illustrate the distribution of the glycinergic axons (green) in the 732 
parvocellular subdivisions of the PVN of originating from the RMg and their relationship to the 733 
TRH neurons (red) in the anterior (B), mid (C) and (D) posterior levels of the PVN. While the 734 
glycinergic axons originating from the RMg densely innervate the parvocellular subdivisions 735 
on both sides of the hypothalamus, only low density of axons are observed in the magnocellular 736 
subdivision (C). High magnification images demonstrate the juxtaposition of glycinergic axons 737 
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of RMg origin to TRH neurons in the anterior (E), mid (F-H) and posterior (I) levels of the 738 
PVN. 739 
A representative image (J) illustrates the AAV-mediated expression of hChR2(H134R)-eYFP 740 
fusion protein in glycinergic neurons of VLPAG of TRH-IRES-tdTOMATO//GlyT2-Cre mice. 741 
Low magnification images illustrate the distribution of the glycinergic axons of VLPAG origin 742 
in the parvocellular subdivision of the PVN and their relationship to TRH neurons (red) at the 743 
anterior (K), mid (L) and (M) posterior levels of the PVN. The gylcinergic input of VLPAG 744 
origin primarily innervates the ipsilateral side, but axons can also be observed on the 745 
contralateral side. High magnification images demonstrate the juxtaposition of the glycinergic 746 
axons of VLPAG origin to TRH neurons at the anterior (N), mid (O,P) and posterior (Q) levels 747 
of the PVN. DAPI counterstaining (blue) was used to facilitate the identification of brain 748 
regions (A-D, J-M). Arrows point to glycinergic axons juxtaposed to TRH neurons. Scale bar 749 
on A and J = 100 µm; on B = 100 µm corresponds to B-D and K-L; on E = 10 µm corresponds 750 




Figure 7. Effect of glycine on the membrane potential and the spiking frequency of TRH 753 
neurons. Bar graphs show changes of membrane potential (A) and the firing frequency (B) of 754 
TRH neurons in a response to glycine in the presence or absence of the glycine receptor 755 
inhibitor, strychnine. Glycine, alone, decreased the membrane potential and completely 756 
inhibited the firing of TRH neurons. Strychnine prevented these effects of glycine. 757 
Representative trace (C) illustrates the effects of glycine on the membrane potential and firing 758 
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rate of a TRH neuron, and the absence of the glycine-induced changes when strychnine is co-759 
administered. To understand whether this effect of glycine is exerted directly on the TRH 760 
neurons, the effect of glycine was studied in the presence of TTX. Bar graph (D) shows the 761 
change of the membrane potential of TRH neurons in the presence of TTX in a response to 762 
glycine in the presence or absence of the glycine receptor inhibitor, strychnine. A representative 763 
trace is shown on (E). Bath application of glycine depolarized the TRH neurons in the presence 764 
of TTX. Strychnine completely prevented this effect of glycine. ** or *** labels significant 765 
difference (P<0.01 or P<0.001, respectively) based on repeated measure ANOVA followed by 766 
Bonferroni post hoc test. Data are expressed as mean ± SEM. Abbreviations: control – CTRL, 767 
glycine – GLY, washout – W and strychnine – STRY. 768 
 769 
Figure 8. Examination of glycinergic spontaneous inhibitory postsynaptic currents on TRH 770 
neurons. Bar graph (A) shows the average frequency of the sIPSCs of TRH neurons in the 771 
presence of glutamate and GABA receptor inhibitors and the effect of strychnine on the 772 
frequency of these currents. A representative trace illustrates that application of strychnine 773 
markedly inhibited the sIPSCs of TRH neurons in the presence of KYNA and gabazine.  774 
* presents significant difference (P<0.05) based on the paired sample t-test. Data are expressed 775 
as mean ± SEM. Abbreviations: strychnine – STRY. 776 
